Zobrazeno 1 - 10
of 33
pro vyhledávání: '"K. Stockwell"'
Publikováno v:
Mine Closure 2022: 15th Conference on Mine Closure.
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::bd2295d5a50332a66cf48d5c4fd5a781
https://doi.org/10.36487/acg_repo/2215_75
https://doi.org/10.36487/acg_repo/2215_75
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
K zobrazení výsledku je třeba se přihlásit.
Autor:
D. K. A. Scheller, Lance A. Smith, Peter Jenner, Sarah Rose, Mahmoud M. Iravani, Michael J. Jackson, K. Stockwell
Publikováno v:
Experimental Neurology. 221:79-85
We previously showed that continuous infusion of rotigotine resulted in less dyskinesia than repeated pulsatile rotigotine administration or repeated oral administration of L-DOPA in MPTP-treated marmosets. Now we investigate whether continuous rotig
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::7d5a6847b9c9d530e73550dd5e7410e3
https://doi.org/10.1016/j.expneurol.2009.10.004
https://doi.org/10.1016/j.expneurol.2009.10.004
Autor:
Lance A. Smith, C. W. Olanow, Sarah Rose, Dieter Scheller, Michael J. Jackson, Mahmoud M. Iravani, Kayhan A. Tayarani-Binazir, K. Stockwell, Peter Jenner
Publikováno v:
Experimental Neurology. 219:533-542
Rotigotine is a novel, non-ergoline dopamine D(3)/D(2)/D(1)-receptor agonist for the treatment of Parkinson's disease that can be continuously delivered by the transdermal route to provide stable plasma levels. Continuous drug delivery should reduce
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::cbaece314265bda947bfa53d50a6cb32
https://doi.org/10.1016/j.expneurol.2009.07.011
https://doi.org/10.1016/j.expneurol.2009.07.011
Autor:
G. Smith, M. Kurylowicz, John M. Martinis, Peter D. Barnes, Simon D. M. White, N. Mirabolfathi, Sunil Golwala, Bernard Sadoulet, Blas Cabrera, P. Meunier, Martin E. Huber, D. S. Akerib, R. J. Gaitskell, Vuk Mandic, R. M. Clarke, R. W. Schnee, P. L. Brink, K. M. Sundqvist, T. A. Shutt, M. Perillo-Isaac, Tarek Saab, W. K. Stockwell, Sae Woo Nam, D. N. Seitz
Publikováno v:
Nuclear Instruments and Methods in Physics Research Section A: Accelerators, Spectrometers, Detectors and Associated Equipment. 591:476-489
The Cryogenic Dark Matter Search (CDMS) experiment employs ultra-cold solid-state detectors to search for rare events resulting from WIMP-nucleus scattering. An innovative detector packaging and readout system has been developed to meet the unusual c
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::154b4a77bbf05d5b03fa5ef678b3d8b3
https://doi.org/10.1016/j.nima.2008.03.103
https://doi.org/10.1016/j.nima.2008.03.103
Autor:
Peter Jenner, Sarah Rose, Marion J. Perren, K. Stockwell, David Virley, Michael J. Jackson, Mahmoud M. Iravani
Publikováno v:
Experimental Neurology. 211:172-179
L-DOPA treatment of Parkinson's disease induces a high incidence of motor complications, notably dyskinesia. Longer acting dopamine agonists, e.g. ropinirole, are thought to produce more continuous dopaminergic stimulation and less severe dyskinesia.
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::3d9585f3b503b487a6394280c718da53
https://doi.org/10.1016/j.expneurol.2008.01.019
https://doi.org/10.1016/j.expneurol.2008.01.019
Autor:
Alexander Breidenbach, Sarah Rose, K. Stockwell, Michael F. Jackson, Dieter Scheller, Peter Jenner, Lance A. Smith
Publikováno v:
Behavioural Pharmacology. 18:155-160
Rotigotine is a nonergolinic dopamine D3/D2/D1-receptor agonist used clinically for the treatment of Parkinson's disease. This study aimed to determine the relationship between peak antiparkinsonian activity and drug plasma levels after administratio
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::3bb8bf2fd5bed7a5d86d233732e366cb
https://doi.org/10.1097/fbp.0b013e3280ebb400
https://doi.org/10.1097/fbp.0b013e3280ebb400
Autor:
Paolo Carminati, Peter Jenner, Sarah Rose, K. Stockwell, Louisa Johnson, Lance A. Smith, Michael J. Jackson
Publikováno v:
European Journal of Pharmacology. 546:82-87
Adenosine A 2a receptor antagonists may represent a novel non-dopaminergic approach to the treatment of Parkinson's disease. However, there is little information available on their ability to reverse motor deficits in 1-methyl-4-phenyl-1, 2, 3, 6-tet
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::262bb31d34f30530da4b47ec988028be
https://doi.org/10.1016/j.ejphar.2006.07.017
https://doi.org/10.1016/j.ejphar.2006.07.017
Autor:
K. Stockwell, Bai-Yun Zeng, Maria Papathanou, Sarah Rose, Mahmoud M. Iravani, Peter Jenner, Michael J. Jackson, Andrew C. McCreary, Isobel Strang
Publikováno v:
King's College London
The treatment of dyskinesia in Parkinson׳s disease remains poor but H3 receptor agonists have been suggested as a novel pharmacological approach. We examined the effects of the H3 agonist, immepip, in 6-OHDA-lesioned rats exhibiting AIMs (abnormal i
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::a0ca8b7e3ede3601fd612c3e45a4fe94
https://pubmed.ncbi.nlm.nih.gov/25160743
https://pubmed.ncbi.nlm.nih.gov/25160743
